|
|
| (17 intermediate revisions by 12 users not shown) |
| label / en | label / en |
| Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1. | | Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 |
| label / en-gb | label / en-gb |
| | | Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 |
| label / ast | label / ast |
| | | Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 |
| description / hy | description / hy |
| գիտական հոդված | | 2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված |
| description / ko | description / ko |
| | | 2005년 논문 |
| description / tg-cyrl | description / tg-cyrl |
| | | мақолаи илмӣ |
| description / ca | description / ca |
| | | article científic |
| description / bg | description / bg |
| | | научна статия |
| description / es | description / es |
| | | artículo científico publicado en 2005 |
| description / lt | description / lt |
| | | mokslinis straipsnis |
| description / vi | description / vi |
| | | bài báo khoa học |
| description / ru | description / ru |
| | | научная статья |
| description / ast | description / ast |
| | | artículu científicu espublizáu en 2005 |
| description / ka | description / ka |
| | | სამეცნიერო სტატია |
| description / zh-my | description / zh-my |
| | | 2005年论文 |
| description / sq | description / sq |
| | | artikull shkencor |
| description / sr-ec | description / sr-ec |
| | | научни чланак |
| description / he | description / he |
| | | מאמר מדעי |
| description / tg | description / tg |
| | | мақолаи илмӣ |
| description / nan | description / nan |
| | | 2005 nî lūn-bûn |
| description / sv | description / sv |
| | | vetenskaplig artikel |
| description / zh-hant | description / zh-hant |
| | | 2005年論文 |
| description / sr-el | description / sr-el |
| | | naučni članak |
| description / eo | description / eo |
| | | scienca artikolo |
| description / yue | description / yue |
| | | 2005年論文 |
| description / zh-hans | description / zh-hans |
| | | 2005年论文 |
| description / nn | description / nn |
| | | vitskapeleg artikkel |
| description / pt-br | description / pt-br |
| | | artigo científico (publicado na 2005) |
| description / hu | description / hu |
| | | tudományos cikk |
| description / zh-hk | description / zh-hk |
| | | 2005年論文 |
| description / et | description / et |
| | | teaduslik artikkel |
| description / zh-tw | description / zh-tw |
| | | 2005年論文 |
| description / oc | description / oc |
| | | article scientific |
| description / el | description / el |
| | | επιστημονικό άρθρο |
| description / tr | description / tr |
| | | bilimsel makale |
| description / zh-cn | description / zh-cn |
| | | 2005年论文 |
| description / nb | description / nb |
| | | vitenskapelig artikkel |
| description / zh-mo | description / zh-mo |
| | | 2005年論文 |
| description / gl | description / gl |
| | | artigo científico |
| description / pl | description / pl |
| | | artykuł naukowy |
| description / th | description / th |
| | | บทความทางวิทยาศาสตร์ |
| description / tl | description / tl |
| | | artikulong pang-agham |
| description / ro | description / ro |
| | | articol științific |
| description / zh-sg | description / zh-sg |
| | | 2005年论文 |
| description / uk | description / uk |
| | | наукова стаття, опублікована в грудні 2005 |
| description / zh | description / zh |
| | | 2005年论文 |
| description / ja | description / ja |
| | | 2005年の論文 |
| description / wuu | description / wuu |
| | | 2005年论文 |
| description / fi | description / fi |
| | | tieteellinen artikkeli |
| description / bn | description / bn |
| | | ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ |
| description / fa | description / fa |
| | | مقالهٔ علمی |
| description / ur | description / ur |
| | | سائنسی مضمون |
| description / hyw | description / hyw |
| | | 2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած |
| Property / original language of film or TV show | |
| | |
| Property / original language of film or TV show: English / rank | |
| Normal rank
| |
| Property / author name string | |
| Cecile Tremblay
| |
| Property / author name string: Cecile Tremblay / rank | |
| Normal rank
| |
| Property / author name string: Cecile Tremblay / qualifier | |
| | |
| Property / author name string: Cecile Tremblay / reference | |
| | |
| Property / title | Property / title |
| Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1. (English)
| | Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 (English) |
| Property / cites work |
| | | |
| Property / cites work: Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults / rank |
| | | Normal rank |
| Property / cites work: Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Acquired QT interval prolongation and HERG: implications for drug discovery and development / rank |
| | | Normal rank |
| Property / cites work: Acquired QT interval prolongation and HERG: implications for drug discovery and development / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. / rank |
| | | Normal rank |
| Property / cites work: Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection / rank |
| | | Normal rank |
| Property / cites work: The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Resistance to enfuvirtide, the first HIV fusion inhibitor / rank |
| | | Normal rank |
| Property / cites work: Resistance to enfuvirtide, the first HIV fusion inhibitor / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542. / rank |
| | | Normal rank |
| Property / cites work: Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding / rank |
| | | Normal rank |
| Property / cites work: A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development / rank |
| | | Normal rank |
| Property / cites work: Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125), a CCR5 antagonist, with other antiretroviral agents in vitro / rank |
| | | Normal rank |
| Property / cites work: Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125), a CCR5 antagonist, with other antiretroviral agents in vitro / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element / rank |
| | | Normal rank |
| Property / cites work: Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Protein design of an HIV-1 entry inhibitor / rank |
| | | Normal rank |
| Property / cites work: Protein design of an HIV-1 entry inhibitor / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: HIV-1 membrane fusion: targets of opportunity / rank |
| | | Normal rank |
| Property / cites work: HIV-1 membrane fusion: targets of opportunity / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1 / rank |
| | | Normal rank |
| Property / cites work: A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1 / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom / rank |
| | | Normal rank |
| Property / cites work: Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV. / rank |
| | | Normal rank |
| Property / cites work: Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia / rank |
| | | Normal rank |
| Property / cites work: Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states. / rank |
| | | Normal rank |
| Property / cites work: Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states. / reference |
| | | |
| Property / cites work |
| | | |
| Property / cites work: Chemokine receptors and HIV entry / rank |
| | | Normal rank |
| Property / cites work: Chemokine receptors and HIV entry / reference |
| | | |
| Property / language of work or name |
| | | |
| Property / language of work or name: English / rank |
| | | Normal rank |
| Property / ResearchGate publication ID |
| | | |
| Property / ResearchGate publication ID: 7464951 / rank |
| | | Normal rank |
| Property / author |
| | | |
| Property / author: Cécile Tremblay / rank |
| | | Normal rank |
| Property / author: Cécile Tremblay / qualifier |
| | | |
| Property / author: Cécile Tremblay / qualifier |
| | | |
| Property / author: Cécile Tremblay / reference |
| | | |
| Property / number of pages |
| | | |
| Property / number of pages: 9 / rank |
| | | Normal rank |
| Property / number of pages: 9 / reference |
| | | |